000848313 001__ 848313
000848313 005__ 20210129234053.0
000848313 0247_ $$2doi$$a10.1007/s11307-017-1116-4
000848313 0247_ $$2ISSN$$a1536-1632
000848313 0247_ $$2ISSN$$a1860-2002
000848313 0247_ $$2Handle$$a2128/19705
000848313 0247_ $$2pmid$$apmid:28895043
000848313 0247_ $$2WOS$$aWOS:000428064400015
000848313 037__ $$aFZJ-2018-03558
000848313 082__ $$a610
000848313 1001_ $$0P:(DE-Juel1)151313$$aNabbi, Danje$$b0
000848313 245__ $$aEffects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX
000848313 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2018
000848313 3367_ $$2DRIVER$$aarticle
000848313 3367_ $$2DataCite$$aOutput Types/Journal article
000848313 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1537362538_2300
000848313 3367_ $$2BibTeX$$aARTICLE
000848313 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000848313 3367_ $$00$$2EndNote$$aJournal Article
000848313 520__ $$aPurpose- Caffeine, a nonselective antagonist of adenosine receptors, is the most popular psychostimulant worldwide. Recently, a protective role of moderate chronic caffeine consumption against neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease has been discussed. Thus, aim of the present study was an in vivo investigation of effects of long-term caffeine consumption on the adenosine A1 receptor (A1AR) in the rat brain.ProceduresSixteen adult, male rats underwent five positron emission tomography (PET) scans with the highly selective A1AR radioligand [18F]CPFPX in order to determine A1AR availability. After the first baseline PET scan, the animals were assigned to two groups: Caffeine treatment and control group. The caffeine-treated animals received caffeinated tap water (30 mg/kg bodyweight/day, corresponding to 4–5 cups of coffee per day in humans) for 12 weeks. Subsequently, caffeine was withdrawn and repeated PET measurements were performed on day 1, 2, 4, and 7 of caffeine withdrawal. The control animals were measured according to the same time schedule.ResultsAt day 1, after 4.4 h of caffeine withdrawal, a significant decrease (− 34.5%, p < 0.001) of whole brain A1AR availability was observed. Unlike all other investigated brain regions in caffeine-treated rats, the hypothalamus and nucleus accumbens showed no significant intraindividual differences between baseline and first withdrawal PET scan. After approximately 27 h of caffeine withdrawal, the region- and group-specific effects disappeared and A1AR availability settled around baseline.ConclusionsThe present study provides evidence that chronic caffeine consumption does not lead to persistent changes in functional availability of cerebral A1ARs which have previously been associated with neuroprotective effects of caffeine. The acute and region-specific decrease in cerebral A1AR availability directly after caffeine withdrawal is most likely caused by residual amounts of caffeine metabolites disguising an unchanged A1AR expression at this early time-point.
000848313 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000848313 588__ $$aDataset connected to CrossRef
000848313 7001_ $$0P:(DE-Juel1)131679$$aElmenhorst, David$$b1
000848313 7001_ $$0P:(DE-Juel1)131712$$aOskamp, Angela$$b2
000848313 7001_ $$0P:(DE-Juel1)156273$$aLaskowski, Stefanie$$b3
000848313 7001_ $$0P:(DE-Juel1)131672$$aBauer, Andreas$$b4
000848313 7001_ $$0P:(DE-Juel1)131691$$aKroll, Tina$$b5$$eCorresponding author
000848313 773__ $$0PERI:(DE-600)2079211-6$$a10.1007/s11307-017-1116-4$$gVol. 20, no. 2, p. 284 - 291$$n2$$p284 - 291$$tMolecular imaging & biology$$v20$$x1860-2002$$y2018
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/Nabbi-Schroeter2018_Article_EffectsOfLong-TermCaffeineCons.pdf$$yRestricted
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/FZJ-2018-03558_Effects%20of%20Long-Term%20Caffeine%20Consumption%20on%20the%20Adenosine%20A1%20Receptor%20in%20the%20Rat%20Brain%20an%20In%20Vivo%20PET%20Study%20with%2018FCPFPX.pdf$$yOpenAccess
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/FZJ-2018-03558_Effects%20of%20Long-Term%20Caffeine%20Consumption%20on%20the%20Adenosine%20A1%20Receptor%20in%20the%20Rat%20Brain%20an%20In%20Vivo%20PET%20Study%20with%2018FCPFPX_figures.pdf$$yOpenAccess
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/Nabbi-Schroeter2018_Article_EffectsOfLong-TermCaffeineCons.gif?subformat=icon$$xicon$$yRestricted
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/Nabbi-Schroeter2018_Article_EffectsOfLong-TermCaffeineCons.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/Nabbi-Schroeter2018_Article_EffectsOfLong-TermCaffeineCons.jpg?subformat=icon-180$$xicon-180$$yRestricted
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/Nabbi-Schroeter2018_Article_EffectsOfLong-TermCaffeineCons.jpg?subformat=icon-640$$xicon-640$$yRestricted
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/Nabbi-Schroeter2018_Article_EffectsOfLong-TermCaffeineCons.pdf?subformat=pdfa$$xpdfa$$yRestricted
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/FZJ-2018-03558_Effects%20of%20Long-Term%20Caffeine%20Consumption%20on%20the%20Adenosine%20A1%20Receptor%20in%20the%20Rat%20Brain%20an%20In%20Vivo%20PET%20Study%20with%2018FCPFPX.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000848313 8564_ $$uhttps://juser.fz-juelich.de/record/848313/files/FZJ-2018-03558_Effects%20of%20Long-Term%20Caffeine%20Consumption%20on%20the%20Adenosine%20A1%20Receptor%20in%20the%20Rat%20Brain%20an%20In%20Vivo%20PET%20Study%20with%2018FCPFPX_figures.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000848313 909CO $$ooai:juser.fz-juelich.de:848313$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000848313 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)151313$$aForschungszentrum Jülich$$b0$$kFZJ
000848313 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131679$$aForschungszentrum Jülich$$b1$$kFZJ
000848313 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131712$$aForschungszentrum Jülich$$b2$$kFZJ
000848313 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131672$$aForschungszentrum Jülich$$b4$$kFZJ
000848313 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131691$$aForschungszentrum Jülich$$b5$$kFZJ
000848313 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000848313 9141_ $$y2018
000848313 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000848313 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000848313 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL IMAGING BIOL : 2015
000848313 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000848313 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000848313 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000848313 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000848313 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000848313 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000848313 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000848313 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000848313 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000848313 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000848313 980__ $$ajournal
000848313 980__ $$aVDB
000848313 980__ $$aUNRESTRICTED
000848313 980__ $$aI:(DE-Juel1)INM-2-20090406
000848313 9801_ $$aFullTexts